NAPKON Vaccination Module
1.0.0 - trial-use
NAPKON Vaccination Module - Local Development build (v1.0.0). See the Directory of published versions
Contents:
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
These define forms used by systems conforming to this implementation guide to capture or expose data to end users
Additional Vaccination Willingness |
Willingness of the patient to receive additional COVID-19 vaccination if officially recommended |
These define constraints on FHIR resources for systems conforming to this implementation guide
Additional Vaccination Willingness |
Response to AdditionalVaccinationWillingnessQuestionnaire |
Allergic Reaction To Vaccination |
Whether a vaccination caused an allergic reaction |
Analgesic Antipyretic Intake After Vaccination |
Whether a patient took analgesic or antipyretic drugs after a vaccination event |
Body Temperature After Vaccination |
Maximal body temperature after a vaccination event (indicating fever) |
COVID-19 Encounter |
Whether a patient underwent medical treatment for COVID-19 |
COVID-19 Immunization |
COVID-19 immunization event |
COVID-19 Oxygen Therapy |
Indicating whether a COVID-19 patient received an oxygen therapy |
Chemotherapy |
Whether a patient is or has been receiving a chemotherapy within the last 3 months |
General Complaints After Vaccination |
General complaints after a vaccination event |
Immunomodulatory Therapy |
Whether a patient is receiving an immunosuppressive or -modulatory therapy |
Medical Treatment For Vaccination Adverse Reaction |
Whether a patient underwent medical treatment for a potential or actual adverse reaction to a vaccination event |
Regular Alcohol Intake |
Whether a patient regularly drinks alcohol |
Regular Alcohol Intake Quantity |
How many alcoholic drinks a patient usually drinks per day |
SARS CoV2 Infection |
Profile to capture the diagnosis of disease caused by 2019 novel coronavirus. |
SARS CoV2 Variant |
Variant/strain of detected SARS CoV2 (Pango Cov-lineage) |
Vaccination Injection Site Erythema |
Size of an erythema at a vaccine injection site |
Vaccination Injection Site Pain |
Pain intensity at vaccine injection site at rest or movement |
Vaccination Injection Site Swelling |
Size of an swelling at a vaccine injection site |
These define sets of codes used by systems conforming to this implementation guide
Analgesics Antipyretics |
Analgetic and antipyretic drugs |
COVID-19 Vaccination Contraindications |
Contraindications precluding COVID-19 vaccination |
COVID-19 Vaccination Reasons |
Individual reason for getting vaccinated against COVID-19 |
COVID-19 Vaccine Codes |
COVID-19 Vaccine Codes (vaccines approved in the European Union) |
CTCAE Grade Value Set |
CTCAE Grades 0 through 5. The grade of the adverse event, determined by CTCAE criteria, where 0 represents confirmation that the given adverse event did NOT occur, and 5 represents death. Note that grade 0 events are generally not reportable, but may be created to give positive confirmation that the clinician assessed or considered a particular AE. |
Complaint Intensity |
Intensity of general complaints |
Detected Not Detected Unknown Undetermined |
Values for laboratory observations |
Encounter Ambulatory Emergency Inpatient |
ValueSet to determine the encounter type of a patient |
Encounter HomeHealth Ambulatory Inpatient |
ValueSet to determine the encounter type of a patient |
General Complaints After Vaccination |
General complaints after vaccination |
Immunosuppressive Immunomodulatory Therapy |
Immunosuppressive and immunomodulatory procedures / therapies codes |
Pain Provoking Factor |
Pain provoking factors |
Present Not Present Undetermined Other |
Values for laboratory observations |
RestrictedEventStatus |
EventStatus value set restricted to codes not-done, active, completed and unknown |
Severity Grading |
Scale to grade the severity of an outcome/condition/observation |
Yes No Unknown |
Yes / No / Unknown |
These define new code systems used by systems conforming to this implementation guide
CTCAE Grade Code System |
Common terminology criteria (CTC) grades associated with the severity of an adverse event, expressed as integers, 0 through 5, with 0 representing no adverse event, and 5 representing death. |
NAPKON Vaccination Module Codes |
NAPKON Vaccination Module Code System - Collection of vaccination module-specific codes that are missing from common terminologies such as SNOMED CT |
These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like
Additional Vaccination Willingness |
Example of a subject who is willing to receive an additional COVID-19 vaccination if it is officially recommended |
Allergic Reaction To Vaccination Instance |
Example of an undetermined state of an allergic reaction cause by a vaccine |
Allergic Reaction To Vaccination Instance |
Example of a free-text answer to an allergic reaction caused by vaccination |
Analgesic Antipyretic Intake After Vaccination |
Example of an antipyretic drug taken after a vaccination event |
Body Temperature After Vaccination |
Example of a not measured body temperature after vaccination |
Body Temperature After Vaccination |
Example of an elevated body temperature after vaccination |
Body Temperature After Vaccination |
Example of an elevated body temperature after vaccination |
Medical Treatment For Vaccination Adverse Reaction |
Example of a patient hospitalized for a potential or actual adverse reaction to a vaccination event |
COVID-19 Oxygen Therapy |
Example of a COVID-19 patient who received an oxygen therapy |
COVID-19 Vaccination Done |
Example of a patient having received a vaccination |
COVID-19 Vaccination Not Done |
Example of a patient not receiving a vaccination due to pregnancy |
COVID-19 Vaccination Not Done Reason Other |
Example of a patient not receiving a vaccination due to a specified (free-text) ‘other reason’ |
Chemotherapy |
Example of a patient not receiving chemotherapy during the last 3 months |
ExamplePatient |
Example patient to be used as reference in other instances |
General Complaints After Vaccination |
Example of a chill after a vaccination event |
Immunomodulatory Therapy |
Example of a patient receiving an immunosuppresive therapy |
Immunomodulatory Therapy |
Example of a patient not receiving an immunosuppresive therapy |
Medical Treatment For Vaccination Adverse Reaction |
Example of a patient treated in the mergency room or by a general practitioner for a potential or actual adverse reaction to a vaccination event |
Medical Treatment For Vaccination Adverse Reaction |
Example of a patient hospitalized for a potential or actual adverse reaction to a vaccination event |
Regular Alcohol Intake |
Example of a patient who drinks a single drink per week |
Regular Alcohol Intake |
Example of a patient who drinks at least 4 drinks per week |
Regular Alcohol Intake |
Example of a patient for whom the alcohol intake is unknown |
Regular Alcohol Intake |
Example of a patient who does no longer drink alcohol |
Regular Alcohol Intake Quantity |
Example of intake of 5 or more alcoholic beverages per day |
Regular Alcohol Intake Quantity |
Example of a patient for whom the quantity is unknown |
SARS CoV2 Infection |
Example of a patient with a SARS CoV2 infection |
SARS CoV2 Infection |
Example of a patient without SARS CoV2 infection |
SARS CoV2 Infection |
Example of an unknown SARS CoV2 infection |
SARS CoV2 Variant |
Example of a SARS CoV2 variant (Pango lineage) |
Vaccination Injection Site Erythema |
Example of a 2.5-5 cm erythema at a vaccine injection site |
Vaccination Injection Site Pain Rest |
Example of mild pain at vaccine injection site at rest and movement |
Vaccination Injection Site Swelling Instance |
Example of a 5.1-10 cm swelling at a vaccine injection site |